A new method to predict prostate cancer outcomes using digital tissue images
Prognostic and Predictive Digital Tissue Image Assay for Prostate Cancer
['FUNDING_R01'] · EMORY UNIVERSITY · NIH-10914784
This study is working on a new digital tool that looks at tissue samples from prostate cancer patients to help doctors figure out who might be at higher risk for their cancer coming back, so they can offer the best treatment options.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10914784 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a digital tissue image assay to better predict the prognosis of prostate cancer patients. By analyzing tissue samples from patients who have undergone surgery or radiation, the study aims to identify those at high risk for cancer recurrence or metastasis. The approach utilizes advanced computer algorithms to extract important features from tissue images, allowing for more accurate risk stratification. This could help doctors determine which patients would benefit from additional therapies, potentially improving treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are prostate cancer patients who have undergone definitive treatment such as surgery or radiation.
Not a fit: Patients with non-prostate cancers or those who have not received definitive treatment for prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized treatment plans for prostate cancer patients, reducing unnecessary therapies and associated side effects.
How similar studies have performed: Previous studies have shown success with similar prognostic approaches in cancer treatment, indicating a promising avenue for this research.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MADABHUSHI, ANANT — EMORY UNIVERSITY
- Study coordinator: MADABHUSHI, ANANT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.